7 According to the Rome Foundation Global Study, over 40% of people meet the criteria for functional gastrointestinal disorders, with IBS alone affecting 1015% of the global population
How Shotsy makes GLP-1 tracking easier Shotsy was built specifically for people using GLP1 medications
Yu Min, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
However, their main audience appears to market to the under 30 female population
Standard dosing Daily dose: 300-600mcg per day Injection frequency: Once daily, preferably in the morning on an empty stomach Administration route: Subcutaneous injection Most users start at 300mcg to assess tolerance, then increase to 500-600mcg if the lower dose is well-tolerated but results are modest
BioLab Sciences, Inc., Re-Gen Active Lab, Inc., Surgenex LLC and Vitti Labs, LLC